Trial ID: | L0814 |
Source ID: | KCT0002441
|
Associated Drug: |
Salsalate
|
Title: |
The comparison of effect between salsalate and placebo in osteoarthritis patients with nonalcoholic fatty liver disease: investigator initiated randomized placebo-controlled double-blind, pilot study.
|
Acronym: |
--
|
Status: |
Recruiting
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
;Diseases of the musculo-skeletal system and connective tissue
|
Interventions: |
Drug : To compare those who took the salsalate (1 tablet = 500 mg) twice a day, 2 g (0 - 4 weeks), 3 g (4 - 8 weeks) with the placebo group in patients with osteoarthritis with nonalcoholic fatty liver
|
Outcome Measures: |
The change of hepatokines;The change of adipokinesThe change of hepatokines;The change of adipokines;The change of fatty liver and fibrosis index;The change of metabolic index;The change of liver function test and lipid profile;The change of inflammation mediators;The change of liver fibrosis factor;The change of symptoms and function of osteoarthritis;Safety (Side effect)
|
Sponsor/Collaborators: |
Koera University Guro Hospital
|
Gender: |
All
|
Age: |
19(Year)No Limit
|
Phases: |
Not applicable
|
Enrollment: |
34
|
Study Type: |
Interventional Study
|
Study Designs: |
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
|
Start Date: |
01/09/2017
|
Completion Date: |
--
|
Results First Posted: |
--
|
Last Update Posted: |
11 March 2019
|
Locations: |
Korea, Republic of
|
URL: |
http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=11346
|